BP’s West Pharmaceutical WST Stock Holding History

BP’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,128	Closed	-$405K	–	533
2021 Q2	$405K	Hold	1,128	–	–	0.02%	466
2021 Q1	$318K	Buy	+1,128	New	+$323K	0.01%	552

Other funds holding WST

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

BP's WST Position: Q3 2021 in Review

BP sold out of West Pharmaceutical (WST) in Q3 2021, closing a stake of 1,128 shares — an estimated $405K sold.

BP first reported a position in WST in Q1 2021 and held it in 2 quarters. The position peaked at $405K in Q2 2021. 670 funds tracked by Wall St. Rank hold WST as of Q3 2021.

BP reported no remaining West Pharmaceutical position as of Q3 2021 after selling out during the quarter.
BP sold 1,128 West Pharmaceutical shares in Q3 2021, an estimated $405K.
BP first reported a position in West Pharmaceutical in Q1 2021 and held it in 2 quarters.
BP's West Pharmaceutical position peaked at $405K in Q2 2021.
670 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2021.

Based on BP's 13F filing for Q3 2021, filed 10 Nov 2021.